TP53 and astrocytoma (excluding glioblastoma): To the best of our knowledge, this is the first study that investigates 1321N1 human astrocytoma cell lines harbouring mut p53, the effect of Rapha Myr®, a novel blend of sulforaphane and hydrolytic enzymes myrosinase capable of improving isothiocyanates’ bioavailability [15].